Millions of people have taken Zantac (or its generic form, "ranitidine") to treat conditions like acid reflux, ulcers, and the occasional bout of heartburn. Zantac was one of the best-selling medications of all time. For decades, doctors and users viewed Zantac as an extremely safe medication—safe enough for people to take daily for years and even during pregnancy. Then testing revealed a potential link between the use of ranitidine products and developing cancer.
Let's take a look at health concerns related to Zantac and ranitidine and the current state of litigation involving this widely used medication.
In September 2019, Valisure, an independent laboratory, conducted tests of commonly-available medications containing ranitidine. The company found that taking these medications could cause high levels of N-Nitrosodimethylamine (NDMA) in the body. NDMA is a substance that the FDA treats as a "probable carcinogen" (a substance that causes cancer).
NDMA is probably safe to consume in small amounts. Foods such as cured meats, beer, fish, cheese, and even vegetables may contain NDMA. But higher exposures over time may increase cancer risk, and sudden exposure to large quantities can be toxic.
The FDA's testing confirmed the presence of NDMA in ranitidine products. Initially, the FDA said the levels of NDMA in ranitidine were similar to the levels you would expect to be exposed to in foods like grilled or smoked meats.
Then came the FDA's alarming request in April 2020 that manufacturers and retailers pull all ranitidine products from the market. Further testing revealed that NDMA levels increased in ranitidine over time, especially when products were stored in places with higher temperatures. Think of that box of Zantac that's been sitting on the store shelf or in your medicine cabinet for six years. The FDA's message is to toss that medication out right away.
Get more details on the potential link between heartburn drugs and cancer (from WebMD).
Surveys of patients at Memorial Sloan Kettering Cancer Center have revealed a link between ranitidine use and cancers of the:
Researchers in the United Kingdom have found that people who use ranitidine regularly are at an increased risk of developing cancers of the:
Research on ranitidine and cancer is still in the early stages. If you've been diagnosed with any type of cancer after regularly taking Zantac, you might want to talk to a lawyer about a potential claim.
The first Zantac-related injury lawsuit was set to go to trial in Illinois state court in August 2022. The plaintiff, Joseph Bayer, said he developed esophageal cancer from taking over-the-counter Zantac. Bayer dropped his lawsuit for "personal health reasons" against the makers of Zantac, after a series of settlements with generic makers of ranitidine products totaling over $500,000. Bayer has the right to refile against the makers of Zantac within a year.
Plaintiffs in ranitidine-related cancer lawsuits typically ask for compensation for their:
Read more about how much your Zantac case might be worth.
Just because you've taken Zantac in the past doesn't necessarily mean you can file a lawsuit. You have to be able to show:
Some types of cancer might be more closely linked to ranitidine exposure than others (see above), but talk to a lawyer if you've been diagnosed with any type of cancer after using a drug containing ranitidine, particularly long-term use of Zantac. You'll need the exact diagnosis you received from your doctor and your treatment plan. (Learn why a diagnosis is crucial.)
The most difficult thing you'll have to show is that your cancer was caused by Zantac and not some other factor like a genetic predisposition.
For example, let's say a plaintiff claims that using Zantac caused him to develop stomach cancer. Let's assume this plaintiff also has the following characteristics:
This plaintiff is going to have a difficult time proving ranitidine is responsible for causing his stomach cancer. According to WebMD, stomach polyps and obesity are risk factors for stomach cancer. And men are twice as likely as women to get stomach cancer. So, the defendant in this Zantac lawsuit is sure to argue that this plaintiff's preexisting conditions are responsible for his stomach cancer, not his use of Zantac.
Ultimately, it would be up to a judge or jury to decide if this plaintiff can prove by a "preponderance of the evidence" (a more likely than not standard) that Zantac caused his stomach cancer. And settlement is always a possibility. Some defendants settle cases that they think they can win, in order to keep litigation costs down and avoid the unpredictability of trial.
Each type of civil lawsuit—personal injury, contract dispute, property damage—has its own deadline to file. Deadlines vary from state to state. If you miss the deadline to file, your lawsuit will be dismissed and you won't be able to file it again.
In a Zantac case, the deadline clock (called the "statute of limitations") typically doesn't start running until the person taking the medication discovers (or should have reasonably discovered) the harm caused by the medication. Or the clock might start on the date the person was diagnosed with or started experiencing symptoms of a health problem caused by the medication.
Figuring out the deadline to file your lawsuit can be tricky. If you need help, talk to a lawyer who specializes in Zantac lawsuits.
The potential link between ranitidine and cancer was only discovered a few years ago. Yet the Zantac litigation is already moving full steam ahead. Depending on the type of harm alleged, Zantac plaintiffs may find themselves in either a class action lawsuit or multi-district litigation.
The initial wave of lawsuits began in late 2019 as soon as the FDA confirmed a potential link between ranitidine and NDMA. The majority of these early cases didn't involve cancer-related injury claims. Instead, some plaintiffs argued that they were deceived into buying ranitidine and asked for refunds. Other non-injured plaintiffs filed claims for "medical monitoring" costs, asking defendants to pay for the long-term costs to monitor them for cancer. Some of these cases are seeking class-action status.
Soon after, lawsuits seeking damages for ranitidine-related cancers were pending in federal and state courts all over the country.
Just over 2,000 claims have been grouped into a federal "multidistrict litigation" (MDL) action (In Re: Zantac (Ranitidine) Products Liability Litigation). The Zantac MDL is being heard by Judge Robin L. Rosenberg in the U.S. District Court for the Southern District of Florida.
A class-action lawsuit is a single lawsuit filed on behalf of a group of people. An MDL action is different. MDL plaintiffs file individual lawsuits, but their lawsuits are grouped together for pretrial matters because they are factually similar. The goal of MDL is to use court time more efficiently and encourage settlement. But before a settlement takes place, a few "test" trials will happen (known as "bellwether" trials).
The results of the bellwether trials are a preview of what all parties involved in the MDL can expect should they go to trial. For example, if all the bellwether cases result in defense verdicts, the defendants might be more inclined to go to trial, or to make low settlement offers. But if many or most of these bellwether trials result in massive jury verdicts in favor of the plaintiffs, then plaintiffs know they have the upper hand in settlement talks.
In January 2022, plaintiffs identified five types of cancer that they will move forward with as part of the Zantac MDL:
As of July 2022, there were around 2,000 lawsuits pending in the Zantac MDL. Thousands more lawsuits are being filed in state courts all over the country by individuals diagnosed with other types of cancer.
The MDL for Zantac is noteworthy because of its size. The litigation involves an ever-growing number of plaintiffs that could reach over 100,000. The plaintiffs' injuries vary widely from case to case.
The court responded to these and other complications by allowing potential plaintiffs (claimants) to file a census plus form (CPF) online. The census asked claimants about their exposure to ranitidine products, including:
The census allowed plaintiffs and defendants to assess the litigation, including the types of claims and damages pending against defendants. The Zantac MDL census also "tolled" (paused) filing deadlines ("statutes of limitation") for claimants who properly filled out the form.
In California, the Judicial Council can coordinate civil actions that share common questions of facts or law. A group of dozens of Ranitidine Product Cases (JCCP No. 5150) has been coordinated in Alameda, California. The judge overseeing the cases set the first of four bellwether trials to begin on February 13, 2023. The remaining bellwether trials will begin in May, August, and October 2023 unless a global settlement is reached, or the court appoints a mediator to negotiate resolutions.
In order to win a Zantac lawsuit, you'll need legal and medical expertise and the resources to go toe-to-toe with high-powered defendants. Having an experienced lawyer on your side can make a big difference in the outcome of your case.
We've all heard stories about the sky-high hourly rates some lawyers charge. But chances are you won't have to pay a lawyer on an hourly basis to handle a Zantac lawsuit. Most lawyers handle cases like these on a "contingency fee" basis. That means if you lose, you don't pay a fee. If you win, the lawyer takes a percentage of what you receive—usually around one-third of the total. Win or lose, you'll probably be on the hook for costs and expenses like court filing fees and expert witness fees.
If you're experiencing health problems that could be linked to your use of Zantac or another ranitidine product, you should talk to a lawyer. Learn more about how to find an attorney for your Zantac (ranitidine) case. You can also connect with a lawyer directly from this page for free.